Search clinical trials for: physician depression

Total 16292 results

Shanghai Mental Health Center
University of Electronic Science and Technology of China; Shanghai Jiao Tong... and other collaborators

Recruiting

Non-invasive BCI and Application Verification for Depressed People

Depression | Bipolar Depression | Major Depressive Disorder

China
Gilead Sciences
Alliance Foundation Trials, LLC.; NSABP Foundation Inc

Recruiting

Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/NSABP B-63) (ASCENT-05)

Triple Negative Breast Cancer

United States
VA Office of Research and Development

Recruiting

Enhancing Mental and Physical Health of Women Veterans (EMPOWER)

Cardiovascular Diseases | Smoking | Hypertension | Obesity | Diabetes Mellitus | Overweight | Depression, Postpartum | Prediabetic State | Pregnancy | Implementation Science | Prevention | Quality Improvement | Cholesterol | Virtual Care

United States
National Cancer Institute (NCI)

Recruiting

Comparing the New Anti-cancer Drug Eribulin With Chemotherapy Against the Usual Chemotherapy Alone in Metastatic Urothelial Cancer

Metastatic Bladder Urothelial Carcinoma | Metastatic Renal Pelvis Urothelial Carcinoma | Metastatic Ureter Urothelial Carcinoma | Metastatic Urethral Urothelial Carcinoma | Metastatic Urothelial Carcinoma | Stage IV Bladder Cancer AJCC v8 | Stage IV Renal Pelvis Cancer AJCC v8 | Stage IV Ureter Cancer... and other conditions

United States
University of Alberta

Recruiting

Mental Health Assessment and Prescribing by Alberta Pharmacists (MAP-AP)

Generalized Anxiety Disorder | Major Depressive Disorder | Pharmacist-Patient Relations

Canada
National Cancer Institute (NCI)

Recruiting

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-Small Cell Lung Cancer, ALCHEMIST Trial

Lung Non-Small Cell Carcinoma | Lung Non-Small Cell Squamous Carcinoma | Lung Non-Squamous Non-Small Cell Carcinoma | Stage II Lung Cancer AJCC v8 | Stage IIIA Lung Cancer AJCC v8 | Stage IIIB Lung Cancer AJCC v8

United States, Guam
Centre for Addiction and Mental Health
The Physicians' Services Incorporated Foundation

Recruiting

Minocycline as Adjunctive Treatment for Treatment Resistant Depression (MINDEP2)

Treatment Resistant Depression

Canada
Centre Hospitalier Charles Perrens, Bordeaux

Recruiting

Treating Depression on a Day-to-day Basis: Development of a Tool for Physicians Based on a Smartphone Application (SMART)

Depression | Brain Diseases | Central Nervous System Diseases | Nervous System Diseases | Psychiatric Disorder

France
Oregon Health and Science University

Recruiting

Reaching Out to Distressed Medical Residents, Fellows and Faculty

Depression | Suicide

United States
VA Office of Research and Development

Completed

Collaborative Care for Women Veterans (CCWV)

Depression | Anxiety | Stress Disorders, Post Traumatic

United States
Centre for Addiction and Mental Health
The Physicians' Services Incorporated Foundation

Completed

rTMS for Suicidality in Opioid Use Disorder

Major Depressive Disorder | Opioid-use Disorder

Canada
Wake Forest University Health Sciences
National Cancer Institute (NCI)

Completed

Stepped-Care Telehealth for Distress in Cancer Survivors (Telehealth)

Quality of Life | Cancer | Fatigue | Anxiety | Sleep Disturbance | Depressive Symptoms | Recurrent Disease

United States
St. Joseph's Healthcare Hamilton

Completed

Reducing Burnout Among Frontline Healthcare Workers During COVID-19 (RESTORE)

Burnout

Canada
SWOG Cancer Research Network
National Cancer Institute (NCI)

Active, not recruiting

Ramucirumab and Pembrolizumab Versus Standard of Care in Treating Patients With Stage IV or Recurrent Non-small Cell Lung Cancer (A Lung-MAP Non-Match Treatment Trial)

Stage IVA Lung Cancer AJCC v8 | Stage IVB Lung Cancer AJCC v8 | Stage IV Lung Cancer AJCC v8 | Recurrent Lung Non-Small Cell Carcinoma

United States
Eli Lilly and Company

No longer available

Duloxetine Compassionate Use in Patients Who Have Completed a Previous Neuroscience Duloxetine Clinical Trial

Generalized Anxiety Disorder | Fibromyalgia | Major Depressive Disorder | Diabetic Peripheral Neuropathic Pain

Australia
Marie Loiselle
Loyola University Chicago

Completed

Effects of Transcendental Meditation on Physician Burnout and Depression

Depression | Burnout, Professional | Insomnia | Resilience | Perceived Stress

United States
Nu-Life Solutions

Suspended

Phase II Trial of Nu-V3 Non-Invasive Nerve Stimulation Device for Chronic Pain, Anxiety, Depression, Sleeplessness (Nu-V3P2RCT)

Depression | Chronic Pain | Anxiety | Sleeplessness

United States
Oslo University Hospital
Akershus University Hospital, Lørenskog, Norway; Koc University Hospital, Istanbul... and other collaborators

Completed

A Comprehensive Wellness Program (SKY) to Mitigate Physician Burnout (SKY)

Depression | Stress | Insomnia | Anxiety | Optimism | Interpersonal Disengagement | Professional Fulfillment | Work Exhaustion | Self-reported Medical Errors | Physician Burnout

Turkey
Tulane University School of Medicine
Spirit of Charity Foundation - University Medical Center

Completed

Use of Death Cafes to Prevent Burnout in ICU Healthcare Employees (STOPTHEBURN)

Depression | Burnout, Professional | Burnout | Burnout, Psychological | Anxiety

United States
Nova Scotia Health Authority

Completed

Evaluation of a Mental Health Physician Support Program in Nova Scotia

Major Depressive Disorder

Canada
University of Arizona
David Lynch Foundation

Withdrawn

Improving the Mental Health of Resident Physicians and Fellows Through Transcendental Meditation

Depression | Burnout, Professional | Stress, Psychological | Job Stress
Shire

Terminated

SPD489 Adult Major Depressive Disorder (MDD) Open-label Safety and Tolerability Rollover Extension Study

Major Depressive Disorder

United States, Spain, Germany, Puerto Rico, Canada, Estonia, South Africa, Czechia, Finland, Chile, Hungary, Mexico, Poland, Romania
Klarisana Physician Services PLLC

Completed

Ketamine Infusion Therapy for the Treatment of PTSD in Paramedics

Anxiety Disorders | Stress Disorders, Post-Traumatic

United States
Ain Shams University

Completed

e-GAB: Electronic Geriatric Assessment Bundle: Development of an Arabic Self-administered Android CGA Application

Depression | Urinary Incontinence | Cognitive Impairment | Malnutrition | Frailty | Disability Physical | Health Services for the Aged

Egypt
Possible
National Institute of Mental Health (NIMH); University of California, San Francisco and other collaborators

Unknown

COMMIT Depression Trial Nepal

Depression

Nepal
Dokuz Eylul University

Unknown

Mental Health Status and Related Factors Among Physical Medicine & Rehabilitation Physicians in the Covid-19 Pandemic

Depression | Covid19 | Insomnia | Anxiety | Coronavirus

Turkey
Brigham and Women's Hospital
Kripalu Center for Yoga and Health

Completed

Feasibility of a Yoga- and Mindfulness-Based Intervention for Resident Physicians

Depression | Stress | Burnout, Professional | Anxiety

United States
Pfizer

Completed

Open-Label Extension Study Of Tofacitinib In Psoriatic Arthritis (OPAL BALANCE)

Arthritis, Psoriatic

Belgium, United States, Canada, Spain, Australia, Taiwan, Czechia, Hungary, Germany, Mexico, Poland, Russian Federation, Slovakia, United Kingdom, Brazil, Bulgaria
Qure Healthcare, LLC
CE Outcomes

Completed

Quality IQ Patient Simulation Physician Practice Measurement and Engagement (Q-IQ)

Depression | Heart Failure | Pain | Hypertension | Diabetes | Osteoarthritis | Asthma

United States
Maria Pacella
University of Pittsburgh Physicians

Withdrawn

Single-dose Ketamine for the Reduction of Pain and Depression in the Emergency Department

Depression | Acute Pain
Eli Lilly and Company

Terminated

A Study of Olanzapine and Fluoxetine for Treatment-resistant Depression

Treatment Resistant Depression

China
Eli Lilly and Company

Completed

A Study of LY2216684 and Theophylline in Healthy Subjects

Major Depressive Disorder

United States
Eli Lilly and Company

Completed

A Study of LY2216684 in Healthy Participants

Major Depressive Disorder

United States
Eli Lilly and Company

Completed

A Study of the Effect of LY2216684 on Lorazepam

Major Depressive Disorder

United Kingdom
Eli Lilly and Company

Completed

A Study to Measure if There is Any Difference in How the Body Breaks Down or Inactivates Either Fluoxetine or LY2216684 When Both of These Medicines Are Given Together.

Major Depressive Disorder

United States
Eli Lilly and Company

Completed

A Study of LY2216684 in Healthy Participants Receiving Albuterol or Propanolol

Major Depressive Disorder

United States
Eli Lilly and Company

Completed

A Study of LY2216684 and Warfarin in Healthy Subjects

Major Depressive Disorder

United States
Eli Lilly and Company

Completed

A Pharmacokinetic Study of the Coadministration of LY2216684 With Sertraline

Major Depressive Disorder

United States
Eli Lilly and Company

Completed

A Study to Evaluate the Effect of Activated Charcoal on the Absorption of LY2216684 in Healthy Subjects

Depressive Disorder, Major

United States
Eli Lilly and Company

Completed

A Study to Evaluate the Effect of Food on LY2216684

Depressive Disorder, Major

United States
Eli Lilly and Company

Completed

A Study to Evaluate the Effect of Genotype on LY2216684

Depressive Disorder, Major

United States
Eli Lilly and Company

Completed

A Study of LY2216684 in Participants With Major Depression Disorder

Major Depressive Disorder

Japan
Eli Lilly and Company

Completed

A Study of LY2216684 in Healthy Females

Depressive Disorder, Major

United States
Eli Lilly and Company

Completed

A Study of LY2216684 in Major Depressive Disorder in Patients Taking Selective Serotonin Reuptake Inhibitors

Major Depressive Disorder

United States
Eli Lilly and Company

Completed

A Study of LY2216684 in Participants With Impaired Hepatic Function

Depressive Disorder, Major

United States
Eli Lilly and Company

Completed

A Pharmacokinetic Study on the Effect of LY2216684 on the Active Metabolite of Clopidogrel

Major Depressive Disorder

United States
Eli Lilly and Company

Completed

A Study of LY2216684 and Digoxin in Healthy Subjects

Major Depressive Disorder

United States
Eli Lilly and Company

Completed

A Study to Evaluate the Effect of Clarithromycin on LY2216684

Depressive Disorder, Major

United States
NYU Langone Health

Completed

Ketamine as a Rapidly-Acting Antidepressant in Depressed Emergency Department Patients

Depression

United States
Centre for Victims of Torture, Nepal
Physicians for Social Responsibility, Finland

Completed

Effectiveness of Non-medical Health Worker (NMHW) Led Counseling on Common Mental Disorders in Rural Mid-western Nepal

Mental Disorders | Depression | Anxiety | Psychological Distress | Coping

Search clinical trials for: physician depression

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in United States

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations